Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Case report

Progressive multifocal cerebral infarction in a young kidney transplant recipient due to thrombotic microangiopathy

Authors: Arash Haghikia, Meike Heeren, Clemens Bockmeyer, Bernd Haubitz, Wilfried Gwinner

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Renal transplant recipients frequently experience neurological complications. Whereas ischemic stroke, cerebral haemorrhage or hypertensive encephalopathy often result from vascular alterations prior to transplantation, other cerebral diseases like CNS infections, primary brain tumors and drug induced neurotoxicity may develop as consequences of the required post-transplant immunosuppressive treatment.

Case presentation

Here we report on an unusual clinical course of a young kidney transplant recipient with a cluster of fulminant necrotic brain lesions within a period of two months due to thrombotic microangiopathy.

Conclusion

Cerebral ischemia in organ transplant recipients should prompt one to consider thrombotic microangiopathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ponticelli C, Campise MR: Neurological complications in kidney transplant recipients. J Nephrol. 2005, 18: 521-528.PubMed Ponticelli C, Campise MR: Neurological complications in kidney transplant recipients. J Nephrol. 2005, 18: 521-528.PubMed
2.
go back to reference Gijtenbeek JM, van den Bent MJ, Vecht CJ: Cyclosporine neurotoxicity: a review. J Neurol. 1999, 246: 339-346. 10.1007/s004150050360.CrossRefPubMed Gijtenbeek JM, van den Bent MJ, Vecht CJ: Cyclosporine neurotoxicity: a review. J Neurol. 1999, 246: 339-346. 10.1007/s004150050360.CrossRefPubMed
3.
go back to reference Lee VH, Wijdicks EF, Manno EM, Rabinstein AA: Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008, 65: 205-210.PubMed Lee VH, Wijdicks EF, Manno EM, Rabinstein AA: Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008, 65: 205-210.PubMed
4.
go back to reference Oliveras A, Roquer J, Puig JM, Rodríguez A, Mir M, Orfila MA, Masramon J, Lloveras J: Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transplant. 2003, 17: 1-8. 10.1034/j.1399-0012.2003.02042.x.CrossRefPubMed Oliveras A, Roquer J, Puig JM, Rodríguez A, Mir M, Orfila MA, Masramon J, Lloveras J: Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transplant. 2003, 17: 1-8. 10.1034/j.1399-0012.2003.02042.x.CrossRefPubMed
5.
go back to reference Sakhuja V, Sud K, Kalra OP, D’Cruz S, Kohli HS, Jha V, Gupta K, Vasishta RK: Central nervous system complications in renal transplant recipients in a tropical environment. J Neurol Sci. 2001, 183: 89-93. 10.1016/S0022-510X(00)00485-8.CrossRefPubMed Sakhuja V, Sud K, Kalra OP, D’Cruz S, Kohli HS, Jha V, Gupta K, Vasishta RK: Central nervous system complications in renal transplant recipients in a tropical environment. J Neurol Sci. 2001, 183: 89-93. 10.1016/S0022-510X(00)00485-8.CrossRefPubMed
6.
go back to reference Satoskara AA, Pelletierb R, Adamsb P, Nadasdya GM, Brodskya S, Pesaventoc T, Henryb M, Nadasdya T: De novo thrombotic microangiopathy in renal allograft biopsies—role of antibody-mediated rejection. Am J Transplant. 2010, 10: 1804-1811. 10.1111/j.1600-6143.2010.03178.x.CrossRef Satoskara AA, Pelletierb R, Adamsb P, Nadasdya GM, Brodskya S, Pesaventoc T, Henryb M, Nadasdya T: De novo thrombotic microangiopathy in renal allograft biopsies—role of antibody-mediated rejection. Am J Transplant. 2010, 10: 1804-1811. 10.1111/j.1600-6143.2010.03178.x.CrossRef
7.
go back to reference Zarifian A, Meleg-Smith S, O’donovan R, Tesi RJ, Batuman V: Cyclosporine- associated thrombotic microangiopathy in renal allografts. Kidney Int. 1999, 55: 2457-2466. 10.1046/j.1523-1755.1999.00492.x.CrossRefPubMed Zarifian A, Meleg-Smith S, O’donovan R, Tesi RJ, Batuman V: Cyclosporine- associated thrombotic microangiopathy in renal allografts. Kidney Int. 1999, 55: 2457-2466. 10.1046/j.1523-1755.1999.00492.x.CrossRefPubMed
8.
go back to reference Le Quintreca M, Zuberc J, Moulind B, Kamare N, Jablonskic M, Lionetg A, Chateleth V, Moussoni C, Mouradj G, Bridouxk F, Cassutol E, Loiratm C, Rondeaun E, Delahoussea M, Fre’meaux-Bacchio V: Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transplant. 2013, 13: 663-675. 10.1111/ajt.12077.CrossRef Le Quintreca M, Zuberc J, Moulind B, Kamare N, Jablonskic M, Lionetg A, Chateleth V, Moussoni C, Mouradj G, Bridouxk F, Cassutol E, Loiratm C, Rondeaun E, Delahoussea M, Fre’meaux-Bacchio V: Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transplant. 2013, 13: 663-675. 10.1111/ajt.12077.CrossRef
9.
go back to reference Zubera J, Le Quintrecb M, Kridc S, Bertoyed C, Gueutine V, Lahochef A, Heyneg N, Ardissinoh G, Chateleti V, L–H N l, Hourmantj M, Niaudetc P, Fre’meaux-Bacchik V, Rondeaul E, Legendrea C, Loiratm C: Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant. 2012, 12: 3337-3354. 10.1111/j.1600-6143.2012.04252.x.CrossRef Zubera J, Le Quintrecb M, Kridc S, Bertoyed C, Gueutine V, Lahochef A, Heyneg N, Ardissinoh G, Chateleti V, L–H N l, Hourmantj M, Niaudetc P, Fre’meaux-Bacchik V, Rondeaul E, Legendrea C, Loiratm C: Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am J Transplant. 2012, 12: 3337-3354. 10.1111/j.1600-6143.2012.04252.x.CrossRef
Metadata
Title
Progressive multifocal cerebral infarction in a young kidney transplant recipient due to thrombotic microangiopathy
Authors
Arash Haghikia
Meike Heeren
Clemens Bockmeyer
Bernd Haubitz
Wilfried Gwinner
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-59

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.